{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T13:46:04Z","timestamp":1762177564714,"version":"build-2065373602"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Howard Hughes Medical Institute Gilliam Fellowship"},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["ACS RSG-22-109-01-CTPS"],"award-info":[{"award-number":["ACS RSG-22-109-01-CTPS"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Cancer Institute of the National Institutes of Health","award":["U01 CA199240"],"award-info":[{"award-number":["U01 CA199240"]}]},{"name":"Karmanos Cancer Institute at Wayne State University","award":["P30CA022453"],"award-info":[{"award-number":["P30CA022453"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s10549-025-07816-1","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:57:17Z","timestamp":1757411837000},"page":"303-317","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prescription and self-reported use of endocrine therapy among Black hormone receptor-positive breast cancer survivors in the Detroit Research on Cancer Survivors cohort"],"prefix":"10.1007","volume":"214","author":[{"given":"Abigail M.","family":"Fielder","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seongho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie J.","family":"Ruterbusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cydnie","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Gottschlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann G.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Beebe-Dimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadeel","family":"Assad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Hamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristen S.","family":"Purrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"7816_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/1471-2407-13-225","volume":"13","author":"H Ma","year":"2013","unstructured":"Ma H, Lu Y, Malone KE, Marchbanks PA, Deapen DM, Spirtas R et al (2013) Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status. BMC Cancer 13:225. https:\/\/doi.org\/10.1186\/1471-2407-13-225","journal-title":"BMC Cancer"},{"key":"7816_CR2","doi-asserted-by":"publisher","first-page":"6100","DOI":"10.1158\/1078-0432.CCR-10-1533","volume":"16","author":"KM O\u2019Brien","year":"2010","unstructured":"O\u2019Brien KM, Cole SR, Tse C-K, Perou CM, Carey LA, Foulkes WD et al (2010) Intrinsic breast tumor subtypes, race, and long-term survival in the carolina breast cancer study. Clin Cancer Res 16:6100\u20136110. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-1533","journal-title":"Clin Cancer Res"},{"key":"7816_CR3","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1200\/JCO.2014.57.1349","volume":"33","author":"ET Warner","year":"2015","unstructured":"Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong Y-N, Edge SB et al (2015) Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol 33:2254\u20132261. https:\/\/doi.org\/10.1200\/JCO.2014.57.1349","journal-title":"J Clin Oncol"},{"key":"7816_CR4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02311","author":"JM Torres","year":"2024","unstructured":"Torres JM, Sodipo MO, Hopkins MF, Chandler PD, Warner ET (2024) Racial differences in breast cancer survival between black and white women according to tumor subtype: a systematic review and meta-analysis. J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.23.02311","journal-title":"J Clin Oncol"},{"key":"7816_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10549-015-3474-4","volume":"152","author":"M D\u2019Arcy","year":"2015","unstructured":"D\u2019Arcy M, Fleming J, Robinson WR, Kirk EL, Perou CM, Troester MA (2015) Race-associated biological differences among luminal a breast tumors. Breast Cancer Res Treat 152:437\u2013448. https:\/\/doi.org\/10.1007\/s10549-015-3474-4","journal-title":"Breast Cancer Res Treat"},{"key":"7816_CR6","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1001\/jamaoncol.2017.0595","volume":"3","author":"D Huo","year":"2017","unstructured":"Huo D, Hu H, Rhie SK, Gamazon ER, Cherniack AD, Liu J et al (2017) Comparison of breast cancer molecular features and survival by African and European ancestry in the cancer genome atlas. JAMA Oncol 3:1654\u20131662. https:\/\/doi.org\/10.1001\/jamaoncol.2017.0595","journal-title":"JAMA Oncol"},{"key":"7816_CR7","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10549-020-05607-4","volume":"181","author":"KS Purrington","year":"2020","unstructured":"Purrington KS, Gorski D, Simon MS, Hastert TA, Kim S, Rosati R et al (2020) Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers. Breast Cancer Res Treat 181:145\u2013154. https:\/\/doi.org\/10.1007\/s10549-020-05607-4","journal-title":"Breast Cancer Res Treat"},{"key":"7816_CR8","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/jnci\/djz206","volume":"112","author":"HC Benefield","year":"2020","unstructured":"Benefield HC, Allott EH, Reeder-Hayes KE, Perou CM, Carey LA, Geradts J et al (2020) Borderline estrogen receptor-positive breast cancers in black and white women. J Natl Cancer Inst 112:728\u2013736. https:\/\/doi.org\/10.1093\/jnci\/djz206","journal-title":"J Natl Cancer Inst"},{"key":"7816_CR9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/tbj.13011","volume":"24","author":"J Keim-Malpass","year":"2018","unstructured":"Keim-Malpass J, Doede A, Camacho F, Kennedy C, Showalter SL (2018) Impact of patient health literacy on surgical treatment of breast cancer. Breast J 24:633\u2013636. https:\/\/doi.org\/10.1111\/tbj.13011","journal-title":"Breast J"},{"key":"7816_CR10","doi-asserted-by":"publisher","first-page":"e612","DOI":"10.3747\/co.20.1598","volume":"20","author":"CM Lin","year":"2013","unstructured":"Lin CM, Jaswal J, Vandenberg T, Tuck A, Brackstone M (2013) Weakly hormone receptor-positive breast cancer and use of adjuvant hormonal therapy. Curr Oncol 20:e612-613. https:\/\/doi.org\/10.3747\/co.20.1598","journal-title":"Curr Oncol"},{"key":"7816_CR11","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s10549-010-1132-4","volume":"126","author":"DL Hershman","year":"2011","unstructured":"Hershman DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L et al (2011) Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat 126:529\u2013537. https:\/\/doi.org\/10.1007\/s10549-010-1132-4","journal-title":"Breast Cancer Res Treat"},{"key":"7816_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10549-012-1961-4","volume":"133","author":"A Wigertz","year":"2012","unstructured":"Wigertz A, Ahlgren J, Holmqvist M, Fornander T, Adolfsson J, Lindman H et al (2012) Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study. Breast Cancer Res Treat 133:367\u2013373. https:\/\/doi.org\/10.1007\/s10549-012-1961-4","journal-title":"Breast Cancer Res Treat"},{"key":"7816_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.breast.2019.01.003","volume":"44","author":"KB Hagen","year":"2019","unstructured":"Hagen KB, Aas T, Kval\u00f8y JT, S\u00f8iland H, Lind R (2019) Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: a 5-year prospective study. Breast 44:52\u201358. https:\/\/doi.org\/10.1016\/j.breast.2019.01.003","journal-title":"Breast"},{"key":"7816_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.breast.2022.01.012","volume":"62","author":"I Yussof","year":"2022","unstructured":"Yussof I, Mohd Tahir NA, Hatah E, Mohamed Shah N (2022) Factors influencing five-year adherence to adjuvant endocrine therapy in breast cancer patients: a systematic review. Breast 62:22\u201335. https:\/\/doi.org\/10.1016\/j.breast.2022.01.012","journal-title":"Breast"},{"key":"7816_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.breast.2014.11.011","volume":"24","author":"S Seneviratne","year":"2015","unstructured":"Seneviratne S, Campbell I, Scott N, Kuper-Hommel M, Kim B, Pillai A et al (2015) Adherence to adjuvant endocrine therapy: is it a factor for ethnic differences in breast cancer outcomes in New Zealand? Breast 24:62\u201367. https:\/\/doi.org\/10.1016\/j.breast.2014.11.011","journal-title":"Breast"},{"key":"7816_CR16","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1089\/jwh.2014.4982","volume":"24","author":"CJ Ursem","year":"2015","unstructured":"Ursem CJ, Bosworth HB, Shelby RA, Hwang W, Anderson RT, Kimmick GG (2015) Adherence to adjuvant endocrine therapy for breast cancer: importance in women with low income. J Womens Health 24:403\u2013408. https:\/\/doi.org\/10.1089\/jwh.2014.4982","journal-title":"J Womens Health"},{"issue":"5","key":"7816_CR17","doi-asserted-by":"publisher","first-page":"578","DOI":"10.18553\/jmcp.2019.25.5.578","volume":"25","author":"VB Sheppard","year":"2019","unstructured":"Sheppard VB, He J, Sutton A, Cromwell L, Adunlin G, Salgado TM et al (2019) Adherence to adjuvant endocrine therapy in insured black and white breast cancer survivors: exploring adherence measures in patient data. J Manag Care Spec Pharm 25(5):578\u2013586. https:\/\/doi.org\/10.18553\/jmcp.2019.25.5.578","journal-title":"J Manag Care Spec Pharm"},{"key":"7816_CR18","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s10549-011-1762-1","volume":"131","author":"JC Livaudais","year":"2012","unstructured":"Livaudais JC, Hershman DL, Habel L, Kushi L, Gomez SL, Li CI et al (2012) Racial\/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat 131:607\u2013617. https:\/\/doi.org\/10.1007\/s10549-011-1762-1","journal-title":"Breast Cancer Res Treat"},{"key":"7816_CR19","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1200\/JCO.2013.54.2258","volume":"32","author":"HJ Burstein","year":"2014","unstructured":"Burstein HJ, Temin S, Anderson H, Buchholz TA, Davidson NE, Gelmon KE et al (2014) Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: American society of clinical oncology clinical practice guideline focused update. J Clin Oncol 32:2255\u20132269. https:\/\/doi.org\/10.1200\/JCO.2013.54.2258","journal-title":"J Clin Oncol"},{"key":"7816_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s10549-005-0324-9","volume":"91","author":"W Du","year":"2005","unstructured":"Du W, Simon MS (2005) Racial disparities in treatment and survival of women with stage I-III breast cancer at a large academic medical center in metropolitan Detroit. Breast Cancer Res Treat 91:243\u2013248. https:\/\/doi.org\/10.1007\/s10549-005-0324-9","journal-title":"Breast Cancer Res Treat"},{"key":"7816_CR21","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1002\/1097-0142(19921115)70:10<2460::AID-CNCR2820701012>3.0.CO;2-A","volume":"70","author":"HB Muss","year":"1992","unstructured":"Muss HB, Hunter CP, Wesley M, Correa P, Chen VW, Greenberg RS et al (1992) Treatment plans for black and white women with stage II node-positive breast cancer: the national cancer institute black\/white cancer survival study experience. Cancer 70:2460\u20132467","journal-title":"Cancer"},{"issue":"7","key":"7816_CR22","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/jnci\/94.7.490","volume":"94","author":"CJ Bradley","year":"2002","unstructured":"Bradley CJ, Given CW, Roberts C (2002) Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst 94(7):490\u2013496. https:\/\/doi.org\/10.1093\/jnci\/94.7.490","journal-title":"J Natl Cancer Inst"},{"key":"7816_CR23","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1001\/jama.2010.793","volume":"303","author":"S Cykert","year":"2010","unstructured":"Cykert S, Dilworth-Anderson P, Monroe MH, Walker P, McGuire FR, Corbie-Smith G et al (2010) Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer. JAMA 303:2368\u20132376. https:\/\/doi.org\/10.1001\/jama.2010.793","journal-title":"JAMA"},{"key":"7816_CR24","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1056\/NEJMsa040609","volume":"351","author":"PB Bach","year":"2004","unstructured":"Bach PB, Pham HH, Schrag D, Tate RC, Hargraves JL (2004) Primary care physicians who treat blacks and whites. N Engl J Med 351:575\u2013584. https:\/\/doi.org\/10.1056\/NEJMsa040609","journal-title":"N Engl J Med"},{"key":"7816_CR25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1023\/B:CACO.0000019511.67989.09","volume":"15","author":"SO Rogers","year":"2004","unstructured":"Rogers SO, Ray WA, Smalley WE (2004) A population-based study of survival among elderly persons diagnosed with colorectal cancer: does race matter if all are insured? (United States). Cancer Causes Control 15:193\u2013199. https:\/\/doi.org\/10.1023\/B:CACO.0000019511.67989.09","journal-title":"Cancer Causes Control"},{"key":"7816_CR26","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1378\/chest.114.3.675","volume":"114","author":"GA Silvestri","year":"1998","unstructured":"Silvestri GA, Handy J, Lackland D, Corley E, Reed CE (1998) Specialists achieve better outcomes than generalists for lung cancer surgery. Chest 114:675\u2013680. https:\/\/doi.org\/10.1378\/chest.114.3.675","journal-title":"Chest"},{"key":"7816_CR27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/archsurg.139.2.151","volume":"139","author":"AM Morris","year":"2004","unstructured":"Morris AM, Billingsley KG, Baxter NN, Baldwin L-M (2004) Racial disparities in rectal cancer treatment: a population-based analysis. Arch Surg 139:151\u2013155. https:\/\/doi.org\/10.1001\/archsurg.139.2.151","journal-title":"Arch Surg"},{"key":"7816_CR28","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1158\/1055-9965.EPI-18-0123","volume":"28","author":"JL Beebe-Dimmer","year":"2019","unstructured":"Beebe-Dimmer JL, Albrecht TL, Baird TE, Ruterbusch JJ, Hastert T, Harper FWK et al (2019) The detroit research on cancer survivors (ROCS) pilot study: a focus on outcomes after cancer in a racially diverse patient population. Cancer Epidemiol Biomarkers Prev 28:666\u2013674. https:\/\/doi.org\/10.1158\/1055-9965.EPI-18-0123","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"7816_CR29","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/cncr.32725","volume":"126","author":"JL Beebe-Dimmer","year":"2020","unstructured":"Beebe-Dimmer JL, Ruterbusch JJ, Harper FWK, Baird TM, Finlay DG, Rundle AG et al (2020) Physical activity and quality of life in African American cancer survivors: the detroit research on cancer survivors study. Cancer 126:1987\u20131994. https:\/\/doi.org\/10.1002\/cncr.32725","journal-title":"Cancer"},{"key":"7816_CR30","unstructured":"Johnson C, Peace S, Adamo P, Fritz A, Percy-Laurry A, Edwards BK. The 2007 Multiple Primary and Histology Coding Rules. Bethesda, MD: National Cancer Institute, Surveillance, Epidemiology, and End Results Program; 2007."},{"key":"7816_CR31","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817\u20132826. https:\/\/doi.org\/10.1056\/NEJMoa041588","journal-title":"N Engl J Med"},{"key":"7816_CR32","doi-asserted-by":"publisher","DOI":"10.1200\/PO.24.00137","volume":"8","author":"SC Van Alsten","year":"2024","unstructured":"Van Alsten SC, Vohra SN, Ivory JM, Hamilton AM, Gao X, Kirk EL et al (2024) Differences in 21-gene and PAM50 recurrence scores in younger and black women with breast cancer. JCO Precis Oncol 8:e2400137. https:\/\/doi.org\/10.1200\/PO.24.00137","journal-title":"JCO Precis Oncol"},{"key":"7816_CR33","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_432442","volume":"44","author":"C Corti","year":"2024","unstructured":"Corti C, Batra-Sharma H, Kelsten M, Shatsky RA, Garrido-Castro AC, Gradishar WJ (2024) Systemic therapy in breast cancer. Am Soc Clin Oncol Educ Book 44:e432442. https:\/\/doi.org\/10.1200\/EDBK_432442","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"7816_CR34","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","volume":"377","author":"H Pan","year":"2017","unstructured":"Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P et al (2017) 20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years. N Engl J Med 377:1836\u20131846. https:\/\/doi.org\/10.1056\/NEJMoa1701830","journal-title":"N Engl J Med"},{"key":"7816_CR35","doi-asserted-by":"publisher","first-page":"202","DOI":"10.20892\/j.issn.2095-3941.2021.0255","volume":"19","author":"PM Manohar","year":"2021","unstructured":"Manohar PM, Davidson NE (2021) Updates in endocrine therapy for metastatic breast cancer. Cancer Biol Med 19:202\u2013212. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2021.0255","journal-title":"Cancer Biol Med"},{"key":"7816_CR36","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10549-023-06997-x","volume":"201","author":"E Rillamas-Sun","year":"2023","unstructured":"Rillamas-Sun E, Kwan ML, Iribarren C, Cheng R, Neugebauer R, Rana JS et al (2023) Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Res Treat 201:117\u2013126. https:\/\/doi.org\/10.1007\/s10549-023-06997-x","journal-title":"Breast Cancer Res Treat"},{"key":"7816_CR37","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1093\/jnci\/djab023","volume":"113","author":"AE Lohmann","year":"2021","unstructured":"Lohmann AE, Soldera SV, Pimentel I, Ribnikar D, Ennis M, Amir E et al (2021) Association of obesity with breast cancer outcome in relation to cancer subtypes: a meta-analysis. JNCI J Natl Cancer Inst 113:1465\u20131475. https:\/\/doi.org\/10.1093\/jnci\/djab023","journal-title":"JNCI J Natl Cancer Inst"},{"key":"7816_CR38","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1200\/JCO.2012.42.0273","volume":"30","author":"EJ Folkerd","year":"2012","unstructured":"Folkerd EJ, Dixon JM, Renshaw L, A\u2019Hern RP, Dowsett M (2012) Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer. JCO 30:2977\u20132980. https:\/\/doi.org\/10.1200\/JCO.2012.42.0273","journal-title":"JCO"},{"key":"7816_CR39","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1038\/bjc.2013.499","volume":"109","author":"G Pfeiler","year":"2013","unstructured":"Pfeiler G, K\u00f6nigsberg R, Hadji P, Fitzal F, Maroske M, Dressel-Ban G et al (2013) Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer. Br J Cancer 109:1522\u20131527. https:\/\/doi.org\/10.1038\/bjc.2013.499","journal-title":"Br J Cancer"},{"key":"7816_CR40","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1200\/JCO.2009.27.2021","volume":"28","author":"I Sestak","year":"2010","unstructured":"Sestak I, Distler W, Forbes JF, Dowsett M, Howell A, Cuzick J (2010) Effect of body mass index on recurrences in Tamoxifen and Anastrozole treated women: an exploratory analysis from the ATAC trial. JCO 28:3411\u20133415. https:\/\/doi.org\/10.1200\/JCO.2009.27.2021","journal-title":"JCO"},{"key":"7816_CR41","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1200\/JCO.2011.40.8666","volume":"30","author":"M Ewertz","year":"2012","unstructured":"Ewertz M, Gray KP, Regan MM, Ejlertsen B, Price KN, Th\u00fcrlimann B et al (2012) Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1\u201398 trial. JCO 30:3967\u20133975. https:\/\/doi.org\/10.1200\/JCO.2011.40.8666","journal-title":"JCO"},{"key":"7816_CR42","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1002\/cncr.34243","volume":"128","author":"VC Jones","year":"2022","unstructured":"Jones VC, Kruper L, Mortimer J, Ashing KT, Seewaldt VL (2022) Understanding drivers of the black:white breast cancer mortality gap: a call for more robust definitions. Cancer 128:2695\u20132697. https:\/\/doi.org\/10.1002\/cncr.34243","journal-title":"Cancer"},{"key":"7816_CR43","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s40615-020-00817-4","volume":"8","author":"AL Sutton","year":"2021","unstructured":"Sutton AL, Hagiwara N, Perera RA, Sheppard VB (2021) Assessing perceived discrimination as reported by black and white women diagnosed with breast cancer. J Racial Ethn Health Disparities 8:589\u2013595. https:\/\/doi.org\/10.1007\/s40615-020-00817-4","journal-title":"J Racial Ethn Health Disparities"},{"key":"7816_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1188\/21.CJON.S1.17-24","volume":"25","author":"JB Vo","year":"2021","unstructured":"Vo JB, Gillman A, Mitchell K, Nolan TS (2021) Health disparities: impact of health disparities and treatment decision-making biases on cancer adverse effects among Black cancer survivors. Clin J Oncol Nurs 25:17\u201324. https:\/\/doi.org\/10.1188\/21.CJON.S1.17-24","journal-title":"Clin J Oncol Nurs"},{"key":"7816_CR45","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1188\/23.CJON.507-513","volume":"27","author":"L Moore","year":"2023","unstructured":"Moore L, Hayes AE (2023) Cancer health literacy in black women with breast cancer: a comprehensive literature review. Clin J Oncol Nurs 27:507\u2013513. https:\/\/doi.org\/10.1188\/23.CJON.507-513","journal-title":"Clin J Oncol Nurs"},{"key":"7816_CR46","doi-asserted-by":"publisher","DOI":"10.3928\/24748307-20170808-01","author":"LA Cartwright","year":"2017","unstructured":"Cartwright LA, Dumenci L, Cassel JB, Thomson MD, Matsuyama RK (2017) Health literacy is an independent predictor of cancer patients\u2019 hospitalizations. HLRP: Health Lit Res Pract. https:\/\/doi.org\/10.3928\/24748307-20170808-01","journal-title":"HLRP: Health Lit Res Pract"},{"key":"7816_CR47","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1007\/s10900-016-0164-z","volume":"41","author":"A Kamimura","year":"2016","unstructured":"Kamimura A, Chernenko A, Nourian MM, Aguilera G, Assasnik N, Ashby J (2016) The role of health literacy in reducing negative perceptions of breast health and treatment among uninsured primary care patients. J Community Health 41:858\u2013863. https:\/\/doi.org\/10.1007\/s10900-016-0164-z","journal-title":"J Community Health"},{"key":"7816_CR48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1080\/00981389.2014.964447","volume":"54","author":"CF Rust","year":"2015","unstructured":"Rust CF, Davis C, Moore MR (2015) Medication adherence skills training for African-American breast cancer survivors: the effects on health literacy, medication adherence, and self-efficacy. Soc Work Health Care 54:33\u201346. https:\/\/doi.org\/10.1080\/00981389.2014.964447","journal-title":"Soc Work Health Care"},{"key":"7816_CR49","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10549-017-4121-z","volume":"162","author":"M P\u00e9rez","year":"2017","unstructured":"P\u00e9rez M, Schootman M, Hall LE, Jeffe DB (2017) Accelerated partial breast irradiation compared with whole breast radiation therapy: a breast cancer cohort study measuring change in radiation side-effects severity and quality of life. Breast Cancer Res Treat 162:329\u2013342. https:\/\/doi.org\/10.1007\/s10549-017-4121-z","journal-title":"Breast Cancer Res Treat"},{"key":"7816_CR50","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/s12885-023-11122-8","volume":"23","author":"FM Eliassen","year":"2023","unstructured":"Eliassen FM, Bl\u00e5fjelldal V, Helland T, Hjorth CF, H\u00f8lland K, Lode L et al (2023) Importance of endocrine treatment adherence and persistence in breast cancer survivorship: a systematic review. BMC Cancer 23:625. https:\/\/doi.org\/10.1186\/s12885-023-11122-8","journal-title":"BMC Cancer"},{"key":"7816_CR51","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1200\/JCO.20.02514","volume":"38","author":"SRD Johnston","year":"2020","unstructured":"Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM et al (2020) Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER2-, node-positive, high-risk, early breast cancer (monarchE). J Clin Oncol 38:3987\u20133998. https:\/\/doi.org\/10.1200\/JCO.20.02514","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07816-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-025-07816-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-025-07816-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T12:48:23Z","timestamp":1762174103000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-025-07816-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["7816"],"URL":"https:\/\/doi.org\/10.1007\/s10549-025-07816-1","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}